| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4006338 | American Journal of Ophthalmology | 2007 | 8 Pages |
Abstract
Intravitreal injection of bevacizumab appears to result in significant short-term improvement of visual acuity and macular edema secondary to vein occlusion. The present report confirms the previous studies. No ocular toxicity or adverse effects were observed. However, prospective, randomized, controlled long-term studies are required with an adequate number of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Sivakami A. Pai, Rohit Shetty, Priya B. Vijayan, G. Venkatasubramaniam, Naresh K. Yadav, Bhujang K. Shetty, Rajesh B. Babu, Kannan M. Narayana,